Cannabismarketcap

NewLake Capital Partners (NLCP) Stock Analysis — October 2026

Last updated: Oct 22, 2026OTC: NLCPCannabis REIT

Executive Summary

NewLake Capital Partners (OTC: NLCP) is a cannabis reit company currently priced at $14.00 per share with a market capitalization of $287.1M. The company generates trailing twelve-month revenue of $47.9M and year-over-year revenue growth of -3.54%. The stock trades on the OTC exchange in the United States market, and is positioned as a mid-cap player within the cannabis sector.

Price
$14.00
+2.01%
Market Cap
$287.1M
OTC
Revenue (TTM)
$47.9M
-3.54% YoY
P/S Ratio
5.99x
EV/Rev —

Key Takeaways

Market Capitalization

NewLake Capital Partners has a market cap of $287.1M, making it a mid-cap cannabis company listed on the OTC.

Revenue Growth

Trailing twelve-month revenue is $47.9M with year-over-year growth of -3.5%. Declining revenue is a concern that warrants attention.

Balance Sheet Health

NewLake Capital Partners reports $25.8M in cash and equivalents; total debt is not reported in our data.

Valuation

The stock trades at a P/S ratio of 5.99x. Multiples are in a moderate range for cannabis stocks.

52-Week Price Position

At $14.00, the stock trades at 41% of its 52-week range ($12.09 – $16.75). The stock is trading mid-range, offering a balanced risk-reward profile.

NewLake Capital Partners Company Overview

NewLake Capital Partners (OTC: NLCP) is a cannabis real estate investment trust (REIT) currently trading at $14.00 per share with a market capitalization of $287.1M. The stock gained +2.01% in the most recent trading session on volume of 59.3K shares. NewLake Capital Partners is headquartered in the United States and employs approximately 0 people. As a participant in the cannabis real estate investment trust (reit) segment, the company operates within one of the most dynamic and rapidly evolving sectors of the North American economy.

On the revenue front, NewLake Capital Partners generated $47.9M in trailing twelve-month (TTM) revenue, reflecting year-over-year growth of -3.5%. This growth rate is outpacing the REIT sector average of -27.3%. Revenue trends in the cannabis industry are closely watched by analysts, as the sector continues to navigate pricing compression, oversupply dynamics in certain markets, and the ongoing burden of IRS Section 280E, which prevents cannabis businesses from deducting ordinary business expenses at the federal level.

Financial Analysis

Revenue (TTM)
$47.9M
Gross Margin
—
Revenue Growth
-3.54%
Cash on Hand
$25.8M
Total Debt
—
Cash Runway
—

NewLake Capital Partners generated $47.9M in trailing twelve-month revenue, reflecting year-over-year growth of -3.54%.

Revenue momentum is a critical metric for cannabis companies, as the industry continues to evolve through shifts in consumer demand, regulatory changes, and competitive dynamics. NewLake Capital Partners's revenue decline of -3.54% is a notable concern that may be attributable to market headwinds, competitive pressure, pricing compression, or strategic transitions. Investors should closely monitor whether this trend stabilizes or accelerates in coming quarters. The cannabis industry's profitability dynamics are heavily influenced by IRS Section 280E, which prevents plant-touching operators from deducting ordinary business expenses for federal income tax purposes, effectively creating tax rates that can exceed 70% of gross profit.

Valuation Analysis

From a valuation perspective, NewLake Capital Partners trades at a price-to-sales (P/S) ratio of 5.99x, which is above the sector median of 5.55x, suggesting the market is pricing in higher growth expectations or a premium for NewLake Capital Partners's market position. Cannabis stock valuations have compressed significantly from their 2021 highs, and current multiples reflect a more mature market environment where investors demand clear paths to profitability. For context, the broader REIT sector contains 4 publicly traded companies tracked by Cannabismarketcap, and NewLake Capital Partners's valuation should be considered within the context of its specific growth profile and competitive positioning.

At a price-to-sales ratio of 5.99x, NewLake Capital Partners's valuation reflects the market's current assessment of the company's growth potential and risk profile. Investors should compare these multiples against both direct sector peers and historical ranges to determine whether NLCP is trading at a premium or discount.

REIT Sector Peer Comparison

CompanyPriceMarket CapP/SEV/RevGross MarginRev Growth
NLCP$14.00$287.1M5.99x——-3.54%
IIPR$54.52$1.46B5.55x——-8.42%
REFI$9.44$241.4M————
AFCG$3.02$68.5M2.79x——-46.20%

Balance Sheet Deep Dive

Cash & Equivalents
$25.8M
Total Debt
—
Net Cash / Debt Position
—

NewLake Capital Partners reports $25.8M in cash and equivalents; total debt is not reported in our data. Access to capital remains a persistent challenge for cannabis companies, particularly plant-touching operators that are excluded from traditional banking services and institutional lending. Many cannabis companies have turned to sale-leaseback transactions, private placements, and at-the-market (ATM) equity offerings to fund operations. NewLake Capital Partners's balance sheet should be evaluated with these industry-specific constraints in mind.

NewLake Capital Partners reports $25.8M in cash and equivalents; total debt is not reported in our data, so a net cash or net debt position cannot be determined.

The company's annual share dilution rate is not reported in our data. With 20.6M shares currently outstanding, any additional equity issuance directly impacts per-share metrics including earnings per share, book value per share, and ownership percentage.

Cannabis REIT Sector Context

Within the Cannabis Real Estate Investment Trust (REIT) sector, NewLake Capital Partners ranks #2 out of 4 companies by market capitalization, commanding a 13.9% share of the sector's total market cap of $2.06B. Cannabis REITs own and lease properties to cannabis operators under long-term triple-net lease arrangements. These trusts provide capital to cannabis companies that often struggle to access traditional financing, while offering investors exposure to the cannabis sector through real estate income. The largest company in the sector by market cap is Innovative Industrial Properties (IIPR) at $1.46B, followed by NewLake Capital Partners (NLCP) at $287.1M.

By revenue, NewLake Capital Partners ranks #2 of 3 sector companies that report revenue, with $47.9M in trailing twelve-month sales. The sector's top revenue generator is Innovative Industrial Properties at $263.7M. Revenue growth of -3.5% year-over-year reflects challenges that may include market headwinds, competitive pressure, or strategic transitions.

NewLake Capital Partners occupies a leading position within the Cannabis Real Estate Investment Trust (REIT) sector. With a P/S ratio of 5.99x, the company's valuation reflects the market's assessment of its growth potential and risk profile relative to the 3 other tracked peers. Investors should evaluate NewLake Capital Partners alongside its direct sector competitors to understand relative value and operational momentum.

Historical Price Performance

52-Week Range41% from low
$12.09
$16.75
Current: $14.00

NewLake Capital Partners (NLCP) currently trades at $14.00, which places the stock at approximately 41% of its 52-week trading range. Over the past twelve months, NLCP has traded as high as $16.75 and as low as $12.09, representing a 38.5% spread between the yearly high and low. The current price sits 16.4% below the 52-week high and 15.8% above the 52-week low. This range provides important context for understanding the stock's recent volatility and where current levels fall within the broader price history.

In the most recent trading session, NLCP rose +2.01% from a previous close of $13.72 to $14.00, on volume of 59.3K shares. This positive session is within the range of normal daily fluctuations for cannabis stocks, which tend to exhibit higher volatility than the broader equity market. The stock has 20,580,766 shares outstanding, giving it a fully diluted market capitalization that investors should factor into their analysis alongside the current $287.1M market cap figure.

Cannabis stocks have historically exhibited significant price volatility driven by regulatory developments, earnings surprises, and shifts in market sentiment toward the sector. NLCP is trading in the middle of its 52-week range, which suggests the stock has room to move in either direction based on fundamental catalysts. Historical price levels should be considered alongside fundamental data — including revenue trends, margin improvement, and balance sheet health — to form a complete investment thesis.

Investment Thesis

A balanced framework for evaluating NewLake Capital Partners (NLCP) as a potential investment, considering both the upside catalysts and downside risks based on the company's current financial data and industry positioning.

Bull Case
1

Revenue stabilization and potential for operational improvements could reignite top-line growth. With TTM revenue of $47.9M, even modest gains in market share or pricing power could meaningfully impact the company's financial trajectory and investor sentiment toward NLCP.

2

Potential for margin recovery as the cannabis market matures and pricing stabilizes. Regulatory reform — particularly the rescheduling of cannabis and elimination of Section 280E tax burdens — could dramatically improve the gross margin profile for NewLake Capital Partners and the broader industry.

3

Federal cannabis reform — including potential rescheduling, banking access via the SAFE Banking Act, or eventual descheduling — would be a transformative catalyst for NewLake Capital Partners and the entire cannabis sector. Any legislative progress could unlock institutional capital flows, improve banking access, and eliminate the Section 280E tax burden that suppresses profitability industry-wide.

Bear Case
1

Declining revenue of -3.54% year-over-year raises concerns about NewLake Capital Partners's competitive positioning and demand trends. Revenue contraction in a growing industry could signal market share losses, pricing pressure, or execution challenges that may persist in the near term.

2

Cannabis companies continue to face restricted access to traditional banking, institutional capital, and federal bankruptcy protections. These structural disadvantages increase the cost of capital and limit NewLake Capital Partners's financial flexibility compared to companies in federally legal industries, creating an uneven competitive landscape.

3

Regulatory uncertainty remains the single largest risk for NewLake Capital Partners and all cannabis investments. Federal prohibition in the United States creates ongoing challenges including Section 280E tax burdens, limited interstate commerce, and the risk of enforcement actions. State-level regulatory changes, licensing moratoriums, and social equity requirements add additional layers of unpredictability that can materially impact the company's operations and growth plans.

Risk Factors

Key risks that investors should consider before investing in NewLake Capital Partners (NLCP). This is not an exhaustive list, and investors should conduct their own due diligence.

Regulatory & Legal Risk

Cannabis remains a Schedule I controlled substance under federal law, creating fundamental legal uncertainty for NewLake Capital Partners and all plant-touching cannabis operators. Changes in federal enforcement policy, state regulatory frameworks, or local ordinances could materially impact the company's operations, licensing, and financial performance. The evolving patchwork of state regulations creates compliance complexity and limits the ability to operate across state lines.

Section 280E Tax Burden

Under IRS Section 280E, cannabis businesses are prohibited from deducting ordinary business expenses for federal income tax purposes. This effectively results in tax rates that can exceed 70% of gross profit for plant-touching operators, significantly reducing cash flow available for reinvestment and debt service. While potential rescheduling could eliminate this burden, the timeline and outcome remain uncertain, and NewLake Capital Partners's profitability metrics should be evaluated with this tax overhang in mind.

Market & Competition Risk

The cannabis industry faces pricing pressure from oversupply in mature markets, competition from the illicit market (which avoids regulatory costs and taxation), and evolving consumer preferences. NewLake Capital Partners competes for market share against both established operators and well-funded new entrants. Price compression in key markets has squeezed margins across the industry, and any worsening of these trends could materially impact the company's revenue and profitability outlook.

Frequently Asked Questions

Common questions about NewLake Capital Partners (NLCP) stock, answered with real-time data from Cannabismarketcap.

What is NewLake Capital Partners's (NLCP) stock price today?

NewLake Capital Partners (NLCP) stock is currently trading at $14.00 per share on the OTC exchange. This represents a daily gain of +2.01% ($0.28) from the previous closing price of $13.72. Over the past 52 weeks, NLCP has traded between a low of $12.09 and a high of $16.75, placing the current price at approximately -16% from its annual high. The stock has a market capitalization of $287.1M, making it a notable cannabis companies tracked by Cannabismarketcap. NewLake Capital Partners operates in the REIT sector, serving the broader cannabis industry.

What is NewLake Capital Partners's market capitalization?

NewLake Capital Partners (NLCP) has a current market capitalization of $287.1M, calculated by multiplying its 20.6M shares outstanding by the current stock price of $14.00. Market capitalization is a key measure of a company's total equity value as perceived by the public market, and it places NewLake Capital Partners among the mid-cap cannabis companies tracked on Cannabismarketcap. Investors often use market cap alongside revenue and profitability metrics to assess relative valuation within the cannabis sector.

What is NewLake Capital Partners's annual revenue?

NewLake Capital Partners (NLCP) reports trailing twelve month (TTM) revenue of $47.9M, reflecting the total sales generated by the company over the most recent four quarters. Revenue has changed -3.54% year-over-year, reflecting a contraction in top-line performance relative to the prior period. The current price-to-sales ratio is 5.99x, which means investors are paying $5.99 for every $1 of annual revenue — a premium valuation in the context of the cannabis sector. Revenue is one of the most closely watched metrics for cannabis companies, as many are still scaling operations in a rapidly evolving regulatory environment. View the full income statement and quarterly revenue breakdown on Cannabismarketcap for detailed trend analysis.

What are NewLake Capital Partners's key financial metrics?

NewLake Capital Partners (NLCP) reports several important financial metrics that investors track closely. The company has a market capitalization of $287.1M, trailing twelve month revenue of $47.9M. NewLake Capital Partners reports $25.8M in cash and equivalents; total debt is not reported in our data. The price-to-sales ratio stands at 5.99x. With 20.6M shares outstanding, investors should consider both the fundamental financial performance and share structure when evaluating NLCP.

What exchange is NLCP listed on?

NewLake Capital Partners trades under the ticker symbol NLCP on the OTC exchange, and the stock is denominated in US dollars (USD). Shares can typically be purchased through most standard brokerage accounts, though some brokers may charge additional fees for OTC-listed securities. The stock sees average daily trading volume of approximately 59.3K shares, which is an important consideration for liquidity and the ability to enter or exit positions without significant price impact.

What sector is NewLake Capital Partners in?

NewLake Capital Partners is classified as a cannabis real estate investment trust (REIT), meaning it operates as a real estate investment trust, owning and leasing properties used for cannabis cultivation and operations. The REIT sector is a key segment of the cannabis market, and investors often compare companies within the same sector to identify relative outperformers. You can compare NLCP with other REIT stocks on Cannabismarketcap's sector page to see how it ranks on metrics like market cap, revenue, and margins.

How does NLCP compare to other cannabis stocks?

You can compare NewLake Capital Partners (NLCP) side-by-side with any cannabis stock on Cannabismarketcap using the dedicated comparison tool. Key comparison metrics include market cap ($287.1M), trailing twelve month revenue ($47.9M), price-to-sales ratio (5.99x). NewLake Capital Partners sits in the REIT sector, so the most relevant peer comparisons would be against other REIT companies, though cross-sector comparisons can also reveal interesting insights about relative valuation. Visit the rankings page to see where NLCP stands across all cannabis companies on metrics like revenue growth (-3.54% YoY), cash position ($25.8M), and employee count (N/A).

What is NLCP's 52-week trading range?

NewLake Capital Partners (NLCP) has traded between a 52-week low of $12.09 and a 52-week high of $16.75, with the current price of $14.00 sitting approximately -16% from the annual high. This range represents a spread of $4.66 (39% from low to high), which reflects the volatility the stock has experienced over the past year. The 52-week range is a commonly used technical indicator that helps investors understand whether a stock is trading near the top or bottom of its recent range, and it can inform decisions about entry and exit points. Cannabis stocks in general tend to exhibit higher volatility than broader market indices due to evolving regulations and market sentiment.

How does NewLake Capital Partners's valuation compare to cannabis industry peers?

NewLake Capital Partners (NLCP) is valued at a market capitalization of $287.1M with a price-to-sales ratio of 5.99x. In the cannabis industry, valuations can vary significantly depending on sector (MSO, LP, Ancillary, etc.), growth rate, and path to profitability. NewLake Capital Partners's current revenue trajectory of -3.54% YoY may result in a lower valuation relative to faster-growing peers. Investors can use the Cannabismarketcap rankings and comparison tools to benchmark NLCP against specific competitors on valuation multiples, growth rates, and profitability.

Is NewLake Capital Partners stock overvalued or undervalued?

Determining whether NewLake Capital Partners (NLCP) is overvalued or undervalued requires analyzing multiple valuation metrics in context. The current price-to-sales ratio of 5.99x is moderate for the cannabis sector, suggesting the market is pricing in some growth expectations. The stock is currently trading at $14.00, which is -16% from its 52-week high of $16.75, with revenue growth of -3.54% YoY. Investors should consider its cash position of $25.8M and the broader cannabis industry outlook when forming a valuation opinion. Cannabismarketcap provides all the data needed for a thorough analysis, but this information should not be considered investment advice.

What are the risks of investing in NewLake Capital Partners?

Investing in NewLake Capital Partners (NLCP) carries several risks that investors should carefully consider. First, the cannabis industry remains federally illegal in the United States, creating regulatory uncertainty that can impact stock prices, banking access, and tax obligations (notably IRC Section 280E). Second, NewLake Capital Partners reports $25.8M in cash (total debt is not reported in our data), which investors should monitor for dilution risk or liquidity concerns. Additionally, the stock has shown a 52-week range of $12.09 to $16.75, reflecting meaningful price volatility. As with all cannabis stocks, investors face risks from changing state regulations, competitive pressures, and the evolving legal landscape. This information is for educational purposes only and is not investment advice.

What is NewLake Capital Partners's cash position and debt level?

NewLake Capital Partners reports $25.8M in cash and equivalents; total debt is not reported in our data. Balance sheet strength is especially important in the cannabis industry, where companies often face limited access to traditional banking and capital markets. Investors should track these metrics over time on Cannabismarketcap to identify trends in cash consumption and debt management.

How many shares outstanding does NewLake Capital Partners have?

NewLake Capital Partners (NLCP) currently has 20.6M shares outstanding, which when multiplied by the current stock price of $14.00 gives the company its market capitalization of $287.1M. Share count is important because all per-share metrics (earnings per share, book value per share, etc.) are directly impacted by changes in shares outstanding. Cannabis companies frequently issue new shares to raise capital, so monitoring dilution trends on Cannabismarketcap is recommended for long-term investors.

Does NewLake Capital Partners pay a dividend?

Most cannabis companies, including NewLake Capital Partners (NLCP), do not currently pay dividends. The cannabis industry is still in a growth phase, and companies typically reinvest available capital into expanding operations, securing new licenses, building out retail and cultivation infrastructure, and navigating complex regulatory requirements. Additionally, the IRC Section 280E tax burden significantly reduces the free cash flow available for shareholder distributions. Investors in cannabis stocks should generally expect returns to come from capital appreciation rather than dividend income. If NewLake Capital Partners initiates a dividend in the future, it would be reported in their SEC filings and reflected on Cannabismarketcap.

How can I research NewLake Capital Partners stock before investing?

To research NewLake Capital Partners (NLCP) before investing, start with the company overview on Cannabismarketcap, which provides current price ($14.00), market cap ($287.1M), and key financial metrics. Next, review the full financial statements page for quarterly revenue trends, margins, and balance sheet details. Check the analyst ratings page for Wall Street consensus and price targets, and the technical analysis page for chart patterns and momentum indicators. Compare NLCP against sector peers using the comparison tool to understand relative valuation. Review recent news coverage for regulatory developments or corporate events. Finally, read the investment analysis page for a comprehensive deep-dive. Cannabis investing carries unique risks including federal illegality, regulatory uncertainty, and limited banking access — always conduct thorough due diligence before making any investment decision.

What does NewLake Capital Partners's market cap of $287.1M mean?

NewLake Capital Partners's market capitalization of $287.1M represents the total market value of all its outstanding shares (20.6M shares multiplied by the current stock price of $14.00). Market cap is the primary measure investors use to classify companies by size: mid-cap companies ($100M–$1B) like NewLake Capital Partners offer a balance between growth potential and stability. In the cannabis sector, market cap is especially important because it determines index weighting, institutional investment eligibility, and often correlates with the company's operational scale and geographic reach. NewLake Capital Partners currently ranks # among cannabis stocks tracked on Cannabismarketcap.

What regulatory risks does NewLake Capital Partners face?

NewLake Capital Partners (NLCP), like all cannabis companies, faces significant regulatory risks that investors should understand. At the federal level, cannabis remains a Schedule I controlled substance in the United States, which restricts banking access, prevents standard business expense deductions under IRC Section 280E, and creates legal uncertainty. NewLake Capital Partners is subject to the evolving regulatory landscape across the jurisdictions where it operates. Potential catalysts include federal rescheduling (which could ease 280E burdens), the SAFE Banking Act (which would improve banking access), and individual state legalization events. Conversely, regulatory setbacks such as license moratoriums, increased enforcement, or unfavorable tax policy changes pose downside risks. Investors should monitor legislative developments closely using Cannabismarketcap's news and legalization tracker.

More NLCP Research & Data

Disclaimer: The information presented on this page is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other kind of advice. Cannabismarketcap does not recommend that any security be bought, sold, or held by you. All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. Cannabis stocks carry additional risks including federal illegality, regulatory uncertainty, limited banking access, and high volatility. Always conduct your own research and consider consulting a qualified financial advisor before making investment decisions.